The LumiraDx Dual-Target SARS-CoV-2 STAR Complete multiplex assay is intended for the detection and differentiation of nucleic acid from two distinct genes from the SARS-CoV-2 genome in nasopharyngeal or anterior nasal swab from individuals suspected of COVID-19.
Not all products are available in all countries and regions. Please check with your local LumiraDx sales representative or distributor for availability in specific markets.